52-week Open Label Safety-Tolerability Study
Recruiting now · Phase 3
Conditions studied: Schizophrenia
In brief
Phase 3, open label, multicenter study designed to assess the long term safety and tolerability of LB-102 for the treatment of adult patients with stable schizophrenia
Key facts
- Study ID
- NCT07369154
- Run by
- LB Pharmaceuticals Inc.
- People needed
- 900
- Starts
- 2026-04-23
- Expected to finish
- 2029-04-01
- Last updated by the study team
- 2026-07-27
Who can join
Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Provide ICF
- Patients clinically stable PANSS </= 70 at screening
- CGI-S </+ 3 at screening
- Medically stable
- BMI 18 -40
- Taking oral antipsychotic treatment for at least 30 days
- Have stable living environment
You may not qualify if…
- Sexually active M/F patients not willing to use highly effective contraception
- Breast feeding
- History of treatment resistance to schizophrenia medications
- DSM-5 current diagnosis other than schizophrenia
- Risk of suicidal behavior
- History or presence of clinically significant cardiovascular, pulmonary, hepatic, renal, hematologic, gastrointestinal, endocrine, immunologic, dermatologic, neurologic, or oncologic disease or any other
Where it is running
- Chandler Clinical Trials — Chandler, Arizona, United States (enrolling)
- Pillar Clinical Research — Bentonville, Arkansas, United States (enrolling)
- Pillar Clinical Research — Little Rock, Arkansas, United States (enrolling)
- Woodland International Research Group — Little Rock, Arkansas, United States (enrolling)
- Advanced Research Center — Anaheim, California, United States (enrolling)
- Synapse Clinical Trials — Cerritos, California, United States (enrolling)
- ProScience Research Group — Culver City, California, United States (enrolling)
- CenExel — Culver City, California, United States (enrolling)
- Synergy San Diego — San Diego, California, United States (enrolling)
- CenExel — Hollywood, Florida, United States (enrolling)
- Segal Trials — Miami Lakes, Florida, United States (enrolling)
- Health Synergy Clinical Research — West Palm Beach, Florida, United States (enrolling)
- CenExel — Atlanta, Georgia, United States (enrolling)
- Accelerated Clinical Trial — Snellville, Georgia, United States (enrolling)
- Pillar Clinical Research — Chicago, Illinois, United States (enrolling)
- CenExel Gaithersburg — Gaithersburg, Maryland, United States (enrolling)
- Arch Clinical Trials — St Louis, Missouri, United States (enrolling)
- Redbird Research — Las Vegas, Nevada, United States (enrolling)
- Neuro-Behavioral Clinical Research — New York, New York, United States (enrolling)
- Neuro-Behavioral Clinical Research — Canton, Ohio, United States (enrolling)
- Adams Clinical — Philadelphia, Pennsylvania, United States (enrolling)
- Adams Clinical — DeSoto, Texas, United States (enrolling)
- Pillar Clinical Research — Richardson, Texas, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.